|

CT-95 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Context Therapeutics Inc.1

Indications

  • Mesothelin-expressing Advanced Cancers1
  • Cholangiocarcinoma Advanced1
  • Malignant Peritoneal Mesothelioma, Advanced1
  • Mesothelin-Expressing Tumors1
  • Mesothelin-positive Advanced Malignant Solid Tumors1

Denver, Colorado1 trial

CT-95 in Advanced Cancers Associated With Mesothelin Expression

Context Investigational Site

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.